Peter Crosby

14 results

Mainstay Medical’s  ReActiv8 device for the treatment of chronic low back pain

Mainstay Medical has passed an “important milestone” on winning access to the key US market for its new implant therapy for people suffering from chro(...)

Mainstay Medical chief executive Peter Crosby; he  will stand down in October of this year. Photograph: Nick Bradshaw

Losses at Dublin-based Mainstay Medical have continued to mount for the first half of 2017. The group reported a loss of $13.27 million (€11.17m) fo(...)

The ReActiv-8 device has begun a new trial aimed at securing a premarket approval for the US.

Medical device firm Mainstay Medical is focusing on entry to the US market after a year that saw it bring its implantable device for sufferers of chro(...)

Mainstay Medical’s has announced the first sale of its ReActiv8 neurostimulator to treat chronic lower back pain  at a hospital in Koblenz, Germany

Mainstay Medical, the Irish developer of a breakthrough device to treat chronic lower back pain, has made its first commercial sale. The company’s Re(...)

Mainstay Medical chief executive Peter Crosby. Photograph: Nick Bradshaw

Medical device firm Mainstay Medical has sought approval to market in Australia its implantable device for chronic low back pain. The Dublin-listed(...)

Mainstay Medical’s chief executive Peter Crosby: The company  raised €30 million in funding in June through a placing of new shares in the business, with the money to be used to drive the commercialisation of its flagship neurostimulator ReActiv8

Dublin-listed Mainstay Medical, developers of an implantable device that targets chronic lower-back pain, has added another US patent to its portfoli(...)

Mainstay Medical chief executive Peter Crosby.

Dublin-listed Mainstay Medical, a company targeting chronic lower back pain with an implantable device, reported a $13.2 million (€11.8 million) loss(...)

Mainstay Medical chief executive Peter Crosby said the fundraising would allow the business to progress its plans to commercialise the business in Europe and the United States “and help improve the lives of millions of people who suffer from chronic low back pain”. (Photograph: Nick Bradshaw)

Mainstay Medical has raised €30 million in funding through a placing of new shares in the business. The money will be used to drive the commecialisat(...)

Mainstay Medical chief executive  Peter Crosby estimates that there is a potential market for its device of more than two million people in the US and Europe. Photograph: Nick Bradshaw

Irish company Mainstay Medical will seek regulatory approval in Europe for its chronic lower back pain device following clinical trial results that co(...)

The company received approval last year from the Food and Drug Administration (FDA) in the US to begin a clinical trial of its implantable neurostimulation system aimed at treating chronic low back pain

Irish medical devices firm Mainstay Medical, which agreed a debt facility of up to $15 million (€13.1 million) earlier this week, has been awarded an (...)

  • 1
  • 2
  • Next
  • Last »